Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord

[1]  C. Salio,et al.  Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord , 2002, Neuroscience.

[2]  M. Clayton,et al.  Modulation of nerve growth factor in peripheral organs by estrogen and progesterone , 2002, Neuroscience.

[3]  V. Morisset,et al.  Possible mechanisms of cannabinoid-induced antinociception in the spinal cord. , 2001, European journal of pharmacology.

[4]  M. Christie,et al.  Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro , 2001, The Journal of physiology.

[5]  Steven F. Maier,et al.  Glial activation: a driving force for pathological pain , 2001, Trends in Neurosciences.

[6]  V. Pickel,et al.  Ultrastructural Localization of the CB1 Cannabinoid Receptor in μ-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus , 2001, The Journal of Neuroscience.

[7]  I. Galve-Roperh,et al.  Control of the cell survival/death decision by cannabinoids , 2001, Journal of Molecular Medicine.

[8]  T. Wenger,et al.  Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study☆ , 2000, Peptides.

[9]  S. Bevan,et al.  Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons , 2000, Neuroscience.

[10]  S. McMahon,et al.  Cannabinoid CB1 Receptor Expression in Rat Spinal Cord , 2000, Molecular and Cellular Neuroscience.

[11]  A. Basbaum,et al.  Spinal cannabinoids are anti-allodynic in rats with persistent inflammation , 1999, Pain.

[12]  M. Herkenham,et al.  Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study , 1999, Neuroscience.

[13]  M. Herkenham,et al.  Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord , 1999, Brain Research.

[14]  J. Glowinski,et al.  Anandamide and WIN 55212‐2 inhibit cyclic AMP formation through G‐protein‐coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes , 1999, The European journal of neuroscience.

[15]  K. Mackie,et al.  A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord , 1999, Journal of neurocytology.

[16]  I. Galve-Roperh,et al.  Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. , 1998, Molecular pharmacology.

[17]  G. Bennett,et al.  The analgesic effects of R(+)-WIN 55,212–2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain , 1997, Neuroscience Letters.

[18]  A. Hohmann,et al.  Suppression of noxious stimulus-evoked expression of fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist , 1996, Neuroscience.

[19]  J. Glowinski,et al.  Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes , 1995, Nature.

[20]  A. Hohmann,et al.  Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. , 1995, Life sciences.

[21]  M. Kaghad,et al.  An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*) , 1995, The Journal of Biological Chemistry.